The conference will discuss and illustrate Public Procurement of Innovations, PPI, within the Life Science sector. The aim is also to inform about the possibilities with PPI and show a more advantageous way to make use of public means.
The public sector in the EU, as elsewhere in the world, is faced with important societal challenges. These include ensuring high-quality affordable healthcare to cope with the impacts of an ageing population, the fight against climate change, improving energy efficiency, ensuring higher quality and better access to education, and being more effective dealing with security threats. Addressing such challenges can require new and better solutions.
Some of the required improvements are so technologically demanding that either no commercially stable solution exists yet on the market, or existing solutions exhibit shortcomings which require new R&D. By developing forward-looking procurement strategies that include R&D procurement to develop new solutions that address these challenges, the public sector can have a significant impact on the mid to long term efficiency and effectiveness of public services, as well as on the innovation performance and the competitiveness of European industry.
The purpose of the conference is to:
- describe the situation in EU in comparison to the rest of the world
- explain the legal framework and highlight points for discussion
- share experiences with stakeholders on identified hurdles, needs and possibilities
- promote good examples, to illustrate how these can be used to meet the challenges mentioned above and at the same time improve competitiveness.
The aim of the Conference is, in coherency with Lisbon, to mobilise Europe for a public procurement of innovation policy in the life science area in order to increase the competitiveness in EU and thereby also increase the industrial development. A large part of the GDP in the member states goes to public procurement, which can be used to drive innovation. By acting as technologically demanding first buyers of new R&D, public procurers can drive innovation from the demand side. This enables European public authorities to innovate the provision of public services faster and creates opportunities for companies in Europe to take international leadership in new markets. Reducing time to market by developing a strong European home market for innovative products and services is key for Europe to create growth and jobs in quickly evolving markets such as the life science sector.
The aim is also to discuss and illustrate public procurement of innovation with stakeholders and hopefully, public procurement of innovation will be become an obvious alternative when planning procurement.
Important questions to be discussed at the conference are: What can public actors do to facilitate the process? And how can private industry contribute (companies, venture capitalists)?
For further information and registration, please visit:
http://www.vinnova.se/...
The event is free of charge.